Albany Molecular Research, Inc. (NASDAQ:AMRI)

CAPS Rating: 4 out of 5

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Recs

0
Player Avatar edrc (82.61) Submitted: 10/24/2006 2:58:31 PM : Outperform Start Price: $11.38 AMRI Score: -77.95

Strong company, recent run up on no news suggest good news coming.

Featured Broker Partners


Advertisement